Oramed Pharmaceuticals (Israel) Top Management

ORMP Stock   8.63  0.02  0.23%   
Analysis of Oramed Pharmaceuticals' management performance can provide insight into the company performance.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oramed Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Oramed Stock refer to our How to Trade Oramed Stock guide.
Symbol  ORMP
Name  Oramed Pharmaceuticals
TypeStock
Country  
 Israel
Exchange  TA

Information on Oramed Pharmaceuticals Leadership is currently not available.

If you believe this information is not accurate please let us know and we will check it out. Check all delisted instruments across multiple markets.

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Oramed Pharmaceuticals Management Team Effectiveness

The company has return on total asset (ROA) of (26.77) % which means that it has lost $26.77 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (78.51) %, meaning that it generated substantial loss on money invested by shareholders. Oramed Pharmaceuticals' management efficiency ratios could be used to measure how well Oramed Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.

Oramed Pharmaceuticals Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Oramed Pharmaceuticals Price Series Summation is a cross summation of Oramed Pharmaceuticals price series and its benchmark/peer.

About Oramed Pharmaceuticals Management Performance

The success or failure of an entity such as Oramed Pharmaceuticals often depends on how effective the management is. Oramed Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Oramed management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Oramed management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in New York, New York. ORAMED PHARMA is traded on Tel Aviv Stock Exchange in Israel.
Please note, the presentation of Oramed Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Oramed Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Oramed Pharmaceuticals' management manipulating its earnings.

Complementary Tools for Oramed Stock analysis

When running Oramed Pharmaceuticals' price analysis, check to measure Oramed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oramed Pharmaceuticals is operating at the current time. Most of Oramed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oramed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oramed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oramed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities